Device Trial Radar · NCT06713239
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Last checked: Nov 19, 2026Latest source record: Jun 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Dec 18, 2024
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Cleerly, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 3, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PARAMOUNT is a prospective randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative software improves: certainty for diagnosis of CAD, control of CAD risk factors and efficiency of ICA referral with appropriate PCI compared to the usual care strategy based on current AHA/ACC guidelines for care of symptomatic patients with suspicion of CAD.
Conditions
- Coronary Artery Disease
Interventions
Cleerly Labs and Cleerly ISCHEMIADevice
Participants in the coronary plaque-based care arm will have CCTA at baseline. CCTA images will be redacted and uploaded to Cleerly, interpreted using Cleerly Labs and Cleerly ISCHEMIA, and archived.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary objective of this study is to determine whether a management strategy improves efficiency and effectiveness.Time frame: Through study completion- an average of 1 year
- The primary objective of this study is to determine whether a management strategy improves efficiency and effectiveness.Time frame: Through study completion- an average of 1 year
- The primary objective of this study is to determine whether a management strategy improves efficiency and effectiveness.Time frame: Through study completion- an average of 1 year
1 more outcomes with a free account
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Cardiology Associates of Mobile
Mobile, Alabama
Valiance Clinical Research- Huntington Park
Huntington Park, California
Cardiovascular Institute of San Diego
San Diego, California
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.